(3R,5E,7S,9R,11E,13S,14R)-14-Ethyl-13-hydroxy-3,5,7,9,13-pentamethyloxacyclotetradeca-5,11-diene-2,4,10-trione
|
|
(3R,5E,7S,9R,11E,13S,14R)-14-Ethyl-13-hydroxy-3,5,7,9,13-pentamethyloxacyclotetradeca-5,11-diene-2,4,10-trione Eigenschaften
- Schmelzpunkt:
- 173 °C
- Siedepunkt:
- 540.1±50.0 °C(Predicted)
- Dichte
- 1.011±0.06 g/cm3(Predicted)
- pka
- 11.32±0.70(Predicted)
Sicherheit
(3R,5E,7S,9R,11E,13S,14R)-14-Ethyl-13-hydroxy-3,5,7,9,13-pentamethyloxacyclotetradeca-5,11-diene-2,4,10-trione Chemische Eigenschaften,Einsatz,Produktion Methoden
(3R,5E,7S,9R,11E,13S,14R)-14-Ethyl-13-hydroxy-3,5,7,9,13-pentamethyloxacyclotetradeca-5,11-diene-2,4,10-trione Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
(3R,5E,7S,9R,11E,13S,14R)-14-Ethyl-13-hydroxy-3,5,7,9,13-pentamethyloxacyclotetradeca-5,11-diene-2,4,10-trione Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 0)Lieferanten
Firmenname | Telefon | Land | Produktkatalog | Edge Rate |
---|
- (3R,5E,7S,9R,11E,13S,14R)-14-Ethyl-13-hydroxy-3,5,7,9,13-pentamethyloxacyclotetradeca-5,11-diene-2,4,10-trione
- Cromycin
- Kromycin
- Erythronolide A, 4,5,10,11-tetradehydro-10-demethyl-3,5,6,11-tetradeoxy-3-oxo-, (4E,10E)-
- 20509-23-3